HeartSciences Inc. (HSCS) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for HeartSciences Inc. (HSCS:NASDAQ), powered by AI.

Current Price
$1.89
P/E Ratio
-0.2
Market Cap
2M
Sector
Healthcare
What is the HeartSciences Inc. stock price forecast?

HeartSciences Inc. is currently trading at $1.89. View real-time AI analysis on Alpha Lenz.

What is HeartSciences Inc. insider trading activity?

View the latest insider trading data for HeartSciences Inc. on Alpha Lenz.

What is HeartSciences Inc.'s P/E ratio?

HeartSciences Inc.'s P/E ratio is -0.2.

HeartSciences Inc.

NASDAQ · HSCS
$1.89+0.05(+2.72%)Pre-marketNASDAQ regular session 09:30–16:00 ET
Ask about HeartSciences Inc.'s future dividend policy...
Alpha Chat Insight

HeartSciences Inc. trades at a P/E of -0.2 (undervalued) with modest ROE of -233.0%.

Ask for details

Company Overview

HeartSciences Inc. is a healthcare company that specializes in the development and commercialization of innovative medical diagnostic solutions. Its primary focus is on cardiac care, aiming to improve the early detection and monitoring of heart disease through advanced technology. HeartSciences is particularly noted for its software-based platform that enhances the capabilities of existing electrocardiogram (ECG) devices by using signal processing and AI-driven algorithms. This enhancement provides medical practitioners with a more detailed analysis of heart conditions, potentially leading to more accurate diagnoses. The company's solutions are designed to be cost-effective and accessible, targeting a range of healthcare facilities, from large hospitals to smaller clinics. HeartSciences is part of the medical technology industry, contributing to the growing field of digital health innovations. By integrating its technology into routine cardiac evaluations, HeartSciences seeks to play a significant role in preventative healthcare and in reducing the burden of cardiovascular diseases globally.

CEOMr. Andrew Simpson
SectorHealthcare
IndustryMedical Devices
Employees15

Company Statistics

FY 2025

Profile

$1.77MMarket Cap
$4.35KRevenue
0.00Shares Out
15Employees

Margins

56.78%Gross
-187053.33%EBITDA
-192013.13%Operating
-201499.52%Pre-Tax
-201499.52%Net

Valuation

-0.20P/E
8.64P/B
407.66EV/Sales
-0.45EV/EBITDA
-0.24P/FCF

Growth (CAGR)

-32.86%Rev 3Yr
-41.63%Rev 5Yr
N/AOp Inc 3Yr
N/AOp Inc 5Yr
N/ANet Inc 3Yr
N/ANet Inc 5Yr

Returns

-127.72%ROA
-233.04%ROE
-120.42%ROIC

Financial Health

$1.10MCash & Cash Equivalents
$2.92MNet Debt
1958.24%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

HeartSciences Inc. (ticker: HSCS) is a company listed on NASDAQ in the Healthcare sector (Medical Devices). It has approximately 15 employees. Market cap is $2M.

The current price is $1.89 with a P/E ratio of -0.2x and P/B of 8.64x.

ROE is -233.04% and operating margin is -192013.13%. Annual revenue is $4,350.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
HeartSciences Inc. (HSCS) Stock Forecast 2026 $1.89 — Price, Financials & Analyst Targets | Alpha Lenz